Log In
BCIQ
Print this Print this
 

Moxifloxacin/dexamethasone

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionMoxifloxacin/dexamethasone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase III
Standard Indication Infectious (unspecified)
Indication DetailsTreat bacterial ocular Inflammation and infections; Treat otic infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today